Solid Biosciences Inc.

NASDAQ: SLDB · Real-Time Price · USD
6.12
-0.05 (-0.81%)
At close: Aug 15, 2025, 3:59 PM

Solid Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
80.23M 74.02M 155.38M 119.14M
Short-Term Investments
68.69M 49.63M 58.34M 88.64M
Long-Term Investments
1.95M 1.83M 1.83M 2.07M
Other Long-Term Assets
366K 209K 175K 94K
Receivables
n/a n/a n/a 110K
Inventory
n/a n/a n/a 6.01M
Other Current Assets
1.65M 2.11M 3M 2.69M
Total Current Assets
157.3M 129.73M 219.64M 222.61M
Property-Plant & Equipment
29.04M 33.16M 38.61M 7.6M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
31.36M 35.2M 40.61M 9.77M
Total Assets
188.66M 164.94M 260.25M 232.38M
Account Payables
4.24M 2.03M 3.24M 4.46M
Deferred Revenue
n/a n/a n/a 8.08M
Short-Term Debt
3.02M 2.32M 2.56M 1.5M
Other Current Liabilities
132K 3.65M 5.82M 4.98M
Total Current Liabilities
30.26M 14.52M 22.51M 23.6M
Long-Term Debt
n/a 23.94M 25.98M 568K
Other Long-Term Liabilities
n/a -23.94M 96K -568K
Total Long-Term Liabilities
21.16M 23.94M 26.08M 568K
Total Liabilities
51.42M 38.46M 48.59M 24.17M
Total Debt
24.18M 26.27M 28.55M 2.06M
Common Stock
40K 20K 20K 112K
Retained Earnings
-783.45M -658.75M -562.74M -476.76M
Comprehensive Income
47K 15K -68K -45K
Shareholders Equity
137.25M 126.48M 211.67M 208.21M
Total Investments
68.69M 49.63M 58.34M 88.64M